Weiss SA, Djureinovic D, Jessel S, Krykbaeva I, et al. A phase I study of APX005M and cabiralizumab with/without nivolumab in patients with melanoma, kidney cancer or non-small cell lung cancer resistant to anti-PD-(L)1. Clin Cancer Res 2021 Jun 17. pii: 1078-0432.CCR-21-0903.
PMID: 34140403